Skip Navigation LinksHome > January/February 2012 - Volume 1 - Issue 1 > An Update on Intravitreal Injections for Macular Diseases:...
Asia-Pacific Journal of Ophthalmology:
doi: 10.1097/APO.0b013e31823e5b72
Review Article

An Update on Intravitreal Injections for Macular Diseases: Friend or Foe?

Chan, Vesta C.K. FRCS; Liu, David T. FRCS; Lam, Dennis S. MD, FRCOphth

Collapse Box


The purpose of this article is to review the role of intravitreal injections of medications in the treatment of the two common macular diseases, macular edema and age related macular degeneration (AMD). We perform literature search by search engine Pubmed till May 2011, using keywords intravitreal injections, age-related macular degeneration and macular edema to retrieve relevant review articles and original papers. To conclude, with advance in technology, intravitreal injections of medications may have become an integral part of our ability to treat a wide range of macular diseases. The use of ranibizumab, pegaptanib in the treatment of neovascular AMD and TA in the treatment of various causes of macular edema have shown promising results in a number of prospective randomized controlled trials, with low risk of complications reported.

© 2012Asia-Pacific Academy of Ophthalmology

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.